Firefly Neuroscience Inc. (AIFF)
3.09
0.09 (3.00%)
At close: Apr 17, 2025, 3:59 PM
3.09
-0.01%
After-hours: Apr 17, 2025, 07:32 PM EDT
Company Description
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders.
The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
It serves pharmaceutical companies and medical practitioners.
Firefly Neuroscience, Inc. is based in Toronto, Canada.
Firefly Neuroscience Inc.

Country | CA |
IPO Date | Nov 28, 2002 |
Industry | Software - Application |
Sector | Technology |
Employees | 13 |
CEO | Greg Lipschitz |
Contact Details
Address: 150 King St W Toronto, ON CA | |
Website | https://fireflyneuro.com |
Stock Details
Ticker Symbol | AIFF |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | n/a |
CUSIP Number | 317970101 |
ISIN Number | US3179701012 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Greg Lipschitz | Chief Executive Officer & Director |
Gil Issachar | Chief Technology Officer |
Paul Krzywicki CPA | Chief Financial Officer & Company Secretary |
Dr. Jason DuBraski | Vice President of Sales |